Several generic drug manufacturers are accused of price-fixing in a lawsuit; the state of Washington offers residents a universally available public option for health insurance; bills proposed by states to limit vaccine exemptions have stalled.
On Friday, 44 states filed a lawsuit that accused several pharmaceutical companies of inflating prices on drugs and making efforts to prevent competition, The Hill reported Saturday. The suit claims that 20 drug manufacturers engaged in price-fixing and had illegally collaborated to divide up the market and increase prices by as much as 1000%. One company, Teva, which denied wrongdoing, was placed at the heart of the controversy and was accused of conspiring to raise prices of 86 drugs between July 2013 and January 2015.
The state of Washington has worked to make a public option for health insurance universally available for its residents, The New York Times reported. The plan was approved last month by state legislature and Governor Jay Inslee is expected to sign it into law today. Prices of a set of tiered plans, which would cover standard services, are expected to be 10% less expensive than comparable private insurance plans.
As the current measles outbreak has rapidly become the worst in decades, state legislatures have failed to limit exemptions that allow families to avoid vaccinating their children, according to The Pew Charitable Trusts. While states such as Arizona, Hawaii, Iowa, and New York had previously proposed bills to remove exemptions, they have either stalled in committee or failed to advance. The CDC has reported 764 measles infections in 23 states this year alone, far eclipsing numbers from recent years.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More